SEARCH

SEARCH BY CITATION

References

  • 1
    Zoulim F, Trépo C. Drug therapy for chronic hepatitis B: Antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 1998; 29:151168.MEDLINE
  • 2
    Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336:347356.MEDLINE
  • 3
    Lin E, Luscombe C, Wang Y, Shaw T, Locarnini S. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo. Antimicrob Agents Chemother 1996; 40:413418.MEDLINE
  • 4
    Shaw T, Amor P, Civitico G, Boyd M, Locarnini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother 1994; 38:719723.MEDLINE
  • 5
    Shaw T, Mok S, Locarnini S. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Hepatology 1996; 24:9961002.MEDLINE
  • 6
    Dannaoui E, Trépo C, Zoulim F. Inhibitory effect of penciclovir-triphosphate on duck hepatitis B virus reverse transcription. Antivir Chem Chemother 1997; 8:3846.
  • 7
    Main J, Brown J, Howells C, Galassini R, Crossey M, Karayiannis P, Georgiou P, et al. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepatitis 1996; 3:211215.
  • 8
    Krüger M, Tillmann H, Trautwein C, Oldhafer K, Boker K, Pichlmayr R, Manns M. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation. A pilot study [Abstract]. Hepatology 1995; 22:219A.
  • 9
    Trépo C, Jezek P, Atkinson G, Boon R. Efficacy of famciclovir in chronic hepatitis B: results of a dose finding study [Abstract]. Hepatology 1996; 24:188A.
  • 10
    Nowak M, Bonhoeffer S, Hill A, Boehme R, Thomas H, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci U S A 1996; 93:43984402.MEDLINE
  • 11
    Dienstag J, Perillo R, Schiff E, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333:16571661.MEDLINE
  • 12
    Lai C-L, Ching C-K, Tung AK-M, Li E, Young J, Hill A, Wong B C-Y., et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 1997; 25:241244.MEDLINE
  • 13
    Arts E, Wainberg M. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrob Agents Chemother 1996; 40:527540.MEDLINE
  • 14
    Xiong Y, Eickbush T. Origin and evolution of retroelements based upon their reverse transcriptase sequence. EMBO J 1990; 9:33533362.MEDLINE
  • 15
    Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structure at 3.5 A resolution if HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992; 256:17831790.MEDLINE
  • 16
    Bartholomeusz A, Locarnini S. Mutations in the hepatitis B virus polymerase gene that are associated with resistance to famciclovir and lamivudine. International Antiviral News 1997; 5:123124.
  • 17
    Bartholomew M, Jansen R, Jeffers L, Reddy K, Johnson L, Bunzendahl H, Condreay LD, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:2022.MEDLINE
  • 18
    Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24:711713.MEDLINE
  • 19
    Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714717.MEDLINE
  • 20
    Honkoop P, Niesters HGM, de Man RAM, Osterhaus ADME, Schalm SW. Lamivudine resistance in immunocompetent chronic hepatitis B: incidence and patterns. J Hepatol 1997; 26:13931395.MEDLINE
  • 21
    Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339:6168.MEDLINE
  • 22
    Perillo R, Rakela J, Martin P, Levy G, Schiff E, Wright T, Dienstag J, et al. Long-term lamivudine therapy of patients with recurrent hepatitis B post-liver transplantation [Abstract]. Hepatology 1997; 26(Suppl):A196.
  • 23
    Aye TT, Bartholomeusz A, Shaw T, Bowden S, Breschkin A, McMillan J, Angus P, et al. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 1997;11481153.
  • 24
    Locarnini SA, Aye TT, Shaw T, De Man R, Angus PW, McCaughan GW, Bartholomeusz A. The emergence of famciclovir resistant mutations in the hepatitis B virus polymerase during therapy following liver transplantation [Abstract]. Hepatology 1997; 26(Suppl):A958.
  • 25
    Tillmann HL, Trautwein C, Bock T, Glowenka M, Krüger M, Böker K, Jäckel E, et al. Response and mutations in patients sequentially treated with lamivudine and famciclovir for recurrent hepatitis B after liver transplantation [Abstract]. Hepatology 1997; 26(Suppl):A1202.
  • 26
    Zhang X, Zoulim F, Habersetzer F, Xiong S, Trépo C. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. J Med Virol 1996; 48:816.MEDLINE
  • 27
    Zoulim F, Seeger C. Reverse transcription in hepatitis B virus is primed by a tyrosine residue of the polymerase. J Virol 1994; 68:613.MEDLINE
  • 28
    Seeger C, Baldwin B, Tennant BC. Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts. J Virol 1989; 63:46654669.MEDLINE
  • 29
    Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral replication in vivo. J Virol 1994; 68:20262030.MEDLINE
  • 30
    Horwich AL, Furtak K, Pugh J, Summers J. Synthesis of hepadnavirus particles that contain replication-defective duck hepatitis B virus genomes in cultures HuH7 cells. J Virol 1990; 64:642650.MEDLINE
  • 31
    Langon T, Pichoud C, Hantz O, Trépo C, Kay A. A novel vector for the study of hepatitis delta virus replication. J Virol Methods 1998; 70:1928.MEDLINE
  • 32
    Günther S, Li B-C, Miska S, Kruger D, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995; 69:54375444.MEDLINE
  • 33
    Norder H, Couroucé A-M, Magnius L. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198:489503.MEDLINE
  • 34
    Locarnini SA. Hepatitis B surface and polymerase gene variants: potential virological and clinical significance. Hepatology 1998; 27:294297.MEDLINE
  • 35
    Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1998; 27:628633.MEDLINE
  • 36
    Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNAseH activity. J Virol 1990; 64:613620.MEDLINE
  • 37
    Wang G, Zoulim F, Leber E, Kitson K, Seeger C. The role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J Virol 1994; 68:84378442.MEDLINE
  • 38
    Boike SC, Pue M, Audet PR, Freed MI, Fairless A, Ilson IE, Zariffa N, et al. Pharmacokinetics of famciclovir in subjects with chronic hepatic disease. J Clin Pharmacol 1994; 34:11991207.MEDLINE
  • 39
    Innaimo SF, Seifer M, Bisacchi GS, Standring DN, Zahler R, Colonno RJ. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother 1997; 41:14441448.MEDLINE
  • 40
    Korba B, Boyd M. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Antimicrob Agents Chemother 1996; 40:12821284.MEDLINE